 | • レポートコード：GIR201105575 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、mRNAワクチン・治療薬の世界市場を調査対象にし、mRNAワクチン・治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（がん治療MRNAワクチン標準化、個別化がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン）、用途別分析（感染症、がん、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Moderna Therapeutics、eTheRNA、BioNTech、CureVac、In-Cell-Art、Translate Bio、Tiba Biotechnology、Argos Therapeutics、Sangamo Therapeutics、Ethris ・メーカー別販売量、売上、市場シェア ・mRNAワクチン・治療薬の地域別市場分析 ・mRNAワクチン・治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・mRNAワクチン・治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・mRNAワクチン・治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・mRNAワクチン・治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・mRNAワクチン・治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・mRNAワクチン・治療薬の種類別市場規模2015-2020：がん治療MRNAワクチン標準化、個別化がん治療MRNAワクチン、感染症治療MRNAワクチン、感染予防MRNAワクチン ・mRNAワクチン・治療薬の用途別市場規模2015-2020：感染症、がん、その他 ・mRNAワクチン・治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global mRNA Vaccines & Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.3%% in the forecast period of 2020 to 2025 and will expected to reach USD 1666.7 million by 2025, from USD 1210.4 million in 2019.
Market segmentation
mRNA Vaccines & Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, mRNA Vaccines & Therapeutics market has been segmented into
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
By Application, mRNA Vaccines & Therapeutics has been segmented into:
Infectious Disease
Cancer
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global mRNA Vaccines & Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level mRNA Vaccines & Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global mRNA Vaccines & Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the mRNA Vaccines & Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and mRNA Vaccines & Therapeutics Market Share Analysis
mRNA Vaccines & Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, mRNA Vaccines & Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the mRNA Vaccines & Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in mRNA Vaccines & Therapeutics are:
Moderna Therapeutics
eTheRNA
BioNTech
CureVac
In-Cell-Art
Translate Bio
Tiba Biotechnology
Argos Therapeutics
Sangamo Therapeutics
Ethris
Among other players domestic and global, mRNA Vaccines & Therapeutics market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe mRNA Vaccines & Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of mRNA Vaccines & Therapeutics, with price, sales, revenue and global market share of mRNA Vaccines & Therapeutics in 2018 and 2019.
Chapter 3, the mRNA Vaccines & Therapeutics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Vaccines & Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, mRNA Vaccines & Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe mRNA Vaccines & Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 mRNA Vaccines & Therapeutics Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global mRNA Vaccines & Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Standardization Of Cancer Treatment MRNA Vaccine
1.2.3 Individualized Cancer Treatment MRNA Vaccine
1.2.4 Infectious Disease Treatment MRNA Vaccine
1.2.5 Infection Prevention MRNA Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global mRNA Vaccines & Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Overview of Global mRNA Vaccines & Therapeutics Market
1.4.1 Global mRNA Vaccines & Therapeutics Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Moderna Therapeutics
2.1.1 Moderna Therapeutics Details
2.1.2 Moderna Therapeutics Major Business
2.1.3 Moderna Therapeutics SWOT Analysis
2.1.4 Moderna Therapeutics Product and Services
2.1.5 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 eTheRNA
2.2.1 eTheRNA Details
2.2.2 eTheRNA Major Business
2.2.3 eTheRNA SWOT Analysis
2.2.4 eTheRNA Product and Services
2.2.5 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 BioNTech
2.3.1 BioNTech Details
2.3.2 BioNTech Major Business
2.3.3 BioNTech SWOT Analysis
2.3.4 BioNTech Product and Services
2.3.5 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 CureVac
2.4.1 CureVac Details
2.4.2 CureVac Major Business
2.4.3 CureVac SWOT Analysis
2.4.4 CureVac Product and Services
2.4.5 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 In-Cell-Art
2.5.1 In-Cell-Art Details
2.5.2 In-Cell-Art Major Business
2.5.3 In-Cell-Art SWOT Analysis
2.5.4 In-Cell-Art Product and Services
2.5.5 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Translate Bio
2.6.1 Translate Bio Details
2.6.2 Translate Bio Major Business
2.6.3 Translate Bio Product and Services
2.6.4 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Tiba Biotechnology
2.7.1 Tiba Biotechnology Details
2.7.2 Tiba Biotechnology Major Business
2.7.3 Tiba Biotechnology Product and Services
2.7.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Argos Therapeutics
2.8.1 Argos Therapeutics Details
2.8.2 Argos Therapeutics Major Business
2.8.3 Argos Therapeutics Product and Services
2.8.4 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Sangamo Therapeutics
2.9.1 Sangamo Therapeutics Details
2.9.2 Sangamo Therapeutics Major Business
2.9.3 Sangamo Therapeutics Product and Services
2.9.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Ethris
2.10.1 Ethris Details
2.10.2 Ethris Major Business
2.10.3 Ethris Product and Services
2.10.4 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Manufacturer (2018-2019)
3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2019
3.3.2 Top 6 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Regions (2015-2020)
4.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Regions (2015-2020)
4.2 North America mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
4.3 Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
4.5 South America mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
5.1.1 North America mRNA Vaccines & Therapeutics Sales and Market Share by Country (2015-2020)
5.1.2 North America mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2015-2020)
5.2 United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
5.3 Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
5.4 Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
6.1.1 Europe mRNA Vaccines & Therapeutics Sales and Market Share by Country (2015-2020)
6.1.2 Europe mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2015-2020)
6.2 Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6.3 UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6.4 France mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6.5 Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
6.6 Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Market Share by Regions (2015-2020)
7.2 China mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7.3 Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7.4 Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7.5 India mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7.6 Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
7.7 Australia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
8.1.1 South America mRNA Vaccines & Therapeutics Sales and Market Share by Country (2015-2020)
8.1.2 South America mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2015-2020)
8.2 Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
8.3 Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
9.3 Turkey mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
9.4 Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
9.5 South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Type (2015-2020)
10.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2015-2020)
10.3 Global mRNA Vaccines & Therapeutics Price by Type (2015-2020)
11 Global mRNA Vaccines & Therapeutics Market Segment by Application
11.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)
11.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2015-2020)
11.3 Global mRNA Vaccines & Therapeutics Price by Application (2015-2020)
12 Market Forecast
12.1 Global mRNA Vaccines & Therapeutics Sales, Revenue and Growth Rate (2021-2025)
12.2 mRNA Vaccines & Therapeutics Market Forecast by Regions (2021-2025)
12.2.1 North America mRNA Vaccines & Therapeutics Market Forecast (2021-2025)
12.2.2 Europe mRNA Vaccines & Therapeutics Market Forecast (2021-2025)
12.2.3 Asia-Pacific mRNA Vaccines & Therapeutics Market Forecast (2021-2025)
12.2.4 South America mRNA Vaccines & Therapeutics Market Forecast (2021-2025)
12.2.5 Middle East & Africa mRNA Vaccines & Therapeutics Market Forecast (2021-2025)
12.3 mRNA Vaccines & Therapeutics Market Forecast by Type (2021-2025)
12.3.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2021-2025)
12.3.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2021-2025)
12.4 mRNA Vaccines & Therapeutics Market Forecast by Application (2021-2025)
12.4.1 Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2021-2025)
12.4.2 Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global mRNA Vaccines & Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of mRNA Vaccines & Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global mRNA Vaccines & Therapeutics Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global mRNA Vaccines & Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors
Table 9. Moderna Therapeutics mRNA Vaccines & Therapeutics Major Business
Table 10. Moderna Therapeutics mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)
Table 11. Moderna Therapeutics SWOT Analysis
Table 12. Moderna Therapeutics mRNA Vaccines & Therapeutics Product and Services
Table 13. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. eTheRNA Basic Information, Manufacturing Base and Competitors
Table 15. eTheRNA mRNA Vaccines & Therapeutics Major Business
Table 16. eTheRNA mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)
Table 17. eTheRNA SWOT Analysis
Table 18. eTheRNA mRNA Vaccines & Therapeutics Product and Services
Table 19. eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. BioNTech Basic Information, Manufacturing Base and Competitors
Table 21. BioNTech mRNA Vaccines & Therapeutics Major Business
Table 22. BioNTech mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)
Table 23. BioNTech SWOT Analysis
Table 24. BioNTech mRNA Vaccines & Therapeutics Product and Services
Table 25. BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. CureVac Basic Information, Manufacturing Base and Competitors
Table 27. CureVac mRNA Vaccines & Therapeutics Major Business
Table 28. CureVac mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)
Table 29. CureVac SWOT Analysis
Table 30. CureVac mRNA Vaccines & Therapeutics Product and Services
Table 31. CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. In-Cell-Art Basic Information, Manufacturing Base and Competitors
Table 33. In-Cell-Art mRNA Vaccines & Therapeutics Major Business
Table 34. In-Cell-Art mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)
Table 35. In-Cell-Art SWOT Analysis
Table 36. In-Cell-Art mRNA Vaccines & Therapeutics Product and Services
Table 37. In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Translate Bio Basic Information, Manufacturing Base and Competitors
Table 39. Translate Bio mRNA Vaccines & Therapeutics Major Business
Table 40. Translate Bio mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)
Table 41. Translate Bio SWOT Analysis
Table 42. Translate Bio mRNA Vaccines & Therapeutics Product and Services
Table 43. Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors
Table 45. Tiba Biotechnology mRNA Vaccines & Therapeutics Major Business
Table 46. Tiba Biotechnology mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)
Table 47. Tiba Biotechnology SWOT Analysis
Table 48. Tiba Biotechnology mRNA Vaccines & Therapeutics Product and Services
Table 49. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
Table 51. Argos Therapeutics mRNA Vaccines & Therapeutics Major Business
Table 52. Argos Therapeutics mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)
Table 53. Argos Therapeutics SWOT Analysis
Table 54. Argos Therapeutics mRNA Vaccines & Therapeutics Product and Services
Table 55. Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors
Table 57. Sangamo Therapeutics mRNA Vaccines & Therapeutics Major Business
Table 58. Sangamo Therapeutics mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)
Table 59. Sangamo Therapeutics SWOT Analysis
Table 60. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product and Services
Table 61. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Ethris Basic Information, Manufacturing Base and Competitors
Table 63. Ethris mRNA Vaccines & Therapeutics Major Business
Table 64. Ethris mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)
Table 65. Ethris SWOT Analysis
Table 66. Ethris mRNA Vaccines & Therapeutics Product and Services
Table 67. Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Global mRNA Vaccines & Therapeutics Sales by Manufacturer (2018-2019) (K Units)
Table 69. Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2018-2019) (USD Million)
Table 70. Global mRNA Vaccines & Therapeutics Sales by Regions (2015-2020) (K Units)
Table 71. Global mRNA Vaccines & Therapeutics Sales Market Share by Regions (2015-2020)
Table 72. Global mRNA Vaccines & Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 73. North America mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)
Table 74. North America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)
Table 75. North America mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 76. North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Table 77. Europe mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)
Table 78. Europe mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)
Table 79. Europe mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 80. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Regions (2015-2020) (K Units)
Table 81. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Regions (2015-2020)
Table 82. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Regions (2015-2020) (USD Million)
Table 83. South America mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)
Table 84. South America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)
Table 85. South America mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 86. South America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Table 87. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)
Table 88. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)
Table 89. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (USD Million)
Table 90. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Table 91. Global mRNA Vaccines & Therapeutics Sales by Type (2015-2020) (K Units)
Table 92. Global mRNA Vaccines & Therapeutics Sales Share by Type (2015-2020)
Table 93. Global mRNA Vaccines & Therapeutics Revenue by Type (2015-2020) (USD Million)
Table 94. Global mRNA Vaccines & Therapeutics Revenue Share by Type (2015-2020)
Table 95. Global mRNA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)
Table 96. Global mRNA Vaccines & Therapeutics Sales Share by Application (2015-2020)
Table 97. Global mRNA Vaccines & Therapeutics Sales Forecast by Regions (2021-2025) (K Units)
Table 98. Global mRNA Vaccines & Therapeutics Market Share Forecast by Regions (2021-2025)
Table 99. Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2021-2025) (K Units)
Table 100. Global mRNA Vaccines & Therapeutics Market Share Forecast by Type (2021-2025)
Table 101. Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2021-2025)
Table 102. Global mRNA Vaccines & Therapeutics Market Share Forecast by Application (2021-2025)
Table 103. Direct Channel Pros & Cons
Table 104. Indirect Channel Pros & Cons
Table 105. Distributors/Traders/ Dealers List
List of Figures
Figure 1. mRNA Vaccines & Therapeutics Picture
Figure 2. Global Sales Market Share of mRNA Vaccines & Therapeutics by Type in 2019
Figure 3. Standardization Of Cancer Treatment MRNA Vaccine Picture
Figure 4. Individualized Cancer Treatment MRNA Vaccine Picture
Figure 5. Infectious Disease Treatment MRNA Vaccine Picture
Figure 6. Infection Prevention MRNA Vaccine Picture
Figure 7. mRNA Vaccines & Therapeutics Sales Market Share by Application in 2019
Figure 8. Infectious Disease Picture
Figure 9. Cancer Picture
Figure 10. Other Picture
Figure 11. Global mRNA Vaccines & Therapeutics Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey mRNA Vaccines & Therapeutics Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2019
Figure 32. Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 mRNA Vaccines & Therapeutics Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 39. Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2018
Figure 40. North America mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
Figure 41. Europe mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
Figure 43. South America mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020)
Figure 45. North America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)
Figure 47. North America mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2018
Figure 48. North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2018
Figure 50. United States mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 55. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2019
Figure 56. Germany mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Regions 2019
Figure 63. Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Regions 2019
Figure 64. China mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2019
Figure 71. South America mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2019
Figure 72. Brazil mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa mRNA Vaccines & Therapeutics Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa mRNA Vaccines & Therapeutics Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global mRNA Vaccines & Therapeutics Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global mRNA Vaccines & Therapeutics Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales mRNA Vaccines & Therapeutics Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales mRNA Vaccines & Therapeutics Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales mRNA Vaccines & Therapeutics Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales mRNA Vaccines & Therapeutics Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales mRNA Vaccines & Therapeutics Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
mRNA癌ワクチン・治療の世界市場 2020年 Market Overview The mRNA Cancer Vaccines and Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…- 牛呼吸器ワクチンの世界市場 2020年 Market Overview The global Cattle Respiratory Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cattle Respirator…
- ペプチドがんワクチンの世界市場 2020年 Market Overview The Peptide Cancer Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 渡航者用ワクチンの世界市場 2020年 Market Overview The Travelers Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 魚ワクチンの世界市場 2020年 Market Overview The Fish Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…